Nsistent with our earlier results from wild-type C57BL/6 mice Dry Eye Disease is denoted by low tear volumes and inflammatory damage to the conjunctiva and/or cornea [42]. As such, dry 18204824 in each experiment). Data for each sample are shown as the median (black square) with upper and lower quartiles (boxed area), and range of the data (error bars). doi:10.1371/journal.pone.0065797.gDry Eye Disease and Defense against P. aeruginosaFigure 3. SP-D expression in EDE before and after P. aeruginosa challenge. Western immunoblot blot analysis of SP-D expression in pooled ocular surface washes from EDE and control mice (10 mice per group) after 5 days EDE induction, and before and 6 h after inoculation with P. aeruginosa strain PAO1 (109 cfu). To normalize for differences in tear volume, equivalent amounts of protein (2 mg) were used in the analysis (BCA protein assay). Purified recombinant SP-D (rSP-D, ,43 kDa monomer), and a relevant number of bacteria suspended in PBS (56103 cfu, see Fig. 2B), were included as positive and negative controls, respectively. SP-D expression in ocular surface washes was increased under EDE conditions before bacterial inoculation. The experiment was repeated once. doi:10.1371/journal.pone.0065797.gwashes) of EDE mice. While corneal colonization was unaffected by dry eye disease in wild-type mice, our data showed that sp-d gene knockout mice showed increased corneal colonization under EDE conditions. Together these data show that dry eye disease does not compromise ocular defenses against P. aeruginosa infection, and suggest that SP-D contributes to ocular defense against infection under EDE conditions.Upregulation of SP-D in ocular surface washes in response to dry eye conditions may reflect a compensatory innate defense response. This would be consistent with previous studies which have suggested that other ocular innate defenses are upregulated in patients with dry eye disease including membrane-associated mucins (e.g. MUC1) [21,43] and human beta-defensins [18,19]. SP-D has antimicrobial, aggregative and opsonizing properties against P. aeruginosa, it is present in tear fluid, inhibits P. aeruginosa internalization by corneal epithelial cells, and it promotes ocu.Nsistent with our earlier results from wild-type C57BL/6 mice Dry Eye Disease is denoted by low tear volumes and inflammatory damage to the conjunctiva and/or cornea [42]. As such, dry 10781694 eye disease has the potential to increase susceptibility to infection. The results of the present study, however, show that induction of dry eye disease in a murine experimental model (EDE) did not increase corneal susceptibility to P. aeruginosa infection with minimal pathology observed in both normal and dry eye mice. The data also showed that EDE resulted in an increase in surfactant protein-D expression at the ocular surface (ocular surface washes) before bacterial inoculation, and this correlated with increased bacterial clearance from the tears (ocular surfaceFigure 2. Ocular clearance of P. aeruginosa in EDE. Levels of viable P. aeruginosa (cfu) in corneal homogenates (A) or ocular surface washes (B) of C57BL/6 EDE mice compared to normal controls (NC) at 6 h post-inoculation with 109 cfu of P. aeruginosa strain PAO1 (T = 0). EDE was induced for 5 days prior to bacterial inoculation. Bacteria were rapidly cleared from the murine ocular surface of both groups of mice after 6 h. Similar bacterial levels were found in corneal homogenates (A), but fewer bacteria were recovered from the ocular surface washes of EDE mice compared to controls (p = 0.049, Mann-Whitney test) (B). Data are representative of three independent experiments ( 5 animals per group 18204824 in each experiment). Data for each sample are shown as the median (black square) with upper and lower quartiles (boxed area), and range of the data (error bars). doi:10.1371/journal.pone.0065797.gDry Eye Disease and Defense against P. aeruginosaFigure 3. SP-D expression in EDE before and after P. aeruginosa challenge. Western immunoblot blot analysis of SP-D expression in pooled ocular surface washes from EDE and control mice (10 mice per group) after 5 days EDE induction, and before and 6 h after inoculation with P. aeruginosa strain PAO1 (109 cfu). To normalize for differences in tear volume, equivalent amounts of protein (2 mg) were used in the analysis (BCA protein assay). Purified recombinant SP-D (rSP-D, ,43 kDa monomer), and a relevant number of bacteria suspended in PBS (56103 cfu, see Fig. 2B), were included as positive and negative controls, respectively. SP-D expression in ocular surface washes was increased under EDE conditions before bacterial inoculation. The experiment was repeated once. doi:10.1371/journal.pone.0065797.gwashes) of EDE mice. While corneal colonization was unaffected by dry eye disease in wild-type mice, our data showed that sp-d gene knockout mice showed increased corneal colonization under EDE conditions. Together these data show that dry eye disease does not compromise ocular defenses against P. aeruginosa infection, and suggest that SP-D contributes to ocular defense against infection under EDE conditions.Upregulation of SP-D in ocular surface washes in response to dry eye conditions may reflect a compensatory innate defense response. This would be consistent with previous studies which have suggested that other ocular innate defenses are upregulated in patients with dry eye disease including membrane-associated mucins (e.g. MUC1) [21,43] and human beta-defensins [18,19]. SP-D has antimicrobial, aggregative and opsonizing properties against P. aeruginosa, it is present in tear fluid, inhibits P. aeruginosa internalization by corneal epithelial cells, and it promotes ocu.
